![]() GTN 8 Apr 2024 | Other | zł0.27 Per Share |
![]() GTN 4 May 2023 | Other | zł0.58 Per Share |
![]() GTN 8 Dec 2022 | Other | zł1 Per Share |
![]() GTN 26 Apr 2013 | Other | zł0.4 Per Share |
21 Nov 2024 Date | | - Cons. EPS | 0.08 EPS |
1 Oct 2024 Date | | - Cons. EPS | 0.03 EPS |
29 May 2024 Date | | - Cons. EPS | 0.02 EPS |
3 Apr 2024 Date | | - Cons. EPS | 0.12 EPS |
20 Nov 2023 Date | | - Cons. EPS | - EPS |
![]() GTN 8 Apr 2024 | Other | zł0.27 Per Share |
![]() GTN 4 May 2023 | Other | zł0.58 Per Share |
![]() GTN 8 Dec 2022 | Other | zł1 Per Share |
![]() GTN 26 Apr 2013 | Other | zł0.4 Per Share |
21 Nov 2024 Date | | - Cons. EPS | 0.08 EPS |
1 Oct 2024 Date | | - Cons. EPS | 0.03 EPS |
29 May 2024 Date | | - Cons. EPS | 0.02 EPS |
3 Apr 2024 Date | | - Cons. EPS | 0.12 EPS |
20 Nov 2023 Date | | - Cons. EPS | - EPS |
Medical Devices Industry | Healthcare Sector | Mr. Mattias Perjos M.Sc. CEO | WSE Exchange | PLGSPR000014 ISIN |
Sweden Country | 11,848 Employees | 23 Apr 2025 Last Dividend | - Last Split | - IPO Date |
Getinge AB (publ), founded in 1904 and headquartered in Gothenburg, Sweden, specializes in providing advanced solutions and products for operating rooms, intensive-care units, and sterilization departments across the global healthcare spectrum. Operating through its three main segments - Acute Care Therapies, Life Science, and Surgical Workflows, Getinge is dedicated to improving patient outcomes and enhancing healthcare workflows. The company extends its market presence through a comprehensive network of sales companies, agents, and distributors spanning the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region.
Getinge's offerings encompass a wide range of medical and life science equipment and solutions, structured into distinct categories: